145 related articles for article (PubMed ID: 12027100)
21. Scanning laser system for photodynamic therapy of choroidal neovascularization.
Obana A; Gohto Y
Lasers Surg Med; 2002; 30(5):370-5. PubMed ID: 12116330
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.
Ciulla TA; Criswell MH; Snyder WJ; Small W
Br J Ophthalmol; 2005 Jan; 89(1):113-9. PubMed ID: 15615758
[TBL] [Abstract][Full Text] [Related]
23. [Photodynamic therapy of pigmented choroidal melanomas in rabbits using hematoporphyrin monomethyl ether].
Ji HX; Zhang F; Gao LQ; Jia LY; Xiong Y; Liang C; Li LQ
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):212-6. PubMed ID: 17605902
[TBL] [Abstract][Full Text] [Related]
24. Experimental selective choriocapillaris photothrombosis using a modified indocyanine green formulation.
Cardillo JA; Jorge R; Costa RA; Nunes SM; Lavinsky D; Kuppermann BD; Tedesco AC; Farah ME
Br J Ophthalmol; 2008 Feb; 92(2):276-80. PubMed ID: 18227207
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness.
Kim RY; Hu LK; Foster BS; Gragoudas ES; Young LH
Ophthalmology; 1996 Dec; 103(12):2029-36. PubMed ID: 9003336
[TBL] [Abstract][Full Text] [Related]
26. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
Huang Y; Xu G; Peng Y; Lin H; Zheng X; Xie M
J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative.
Husain D; Miller JW; Kenney AG; Michaud N; Flotte TJ; Gragoudas ES
Ophthalmology; 1997 Aug; 104(8):1242-50. PubMed ID: 9261310
[TBL] [Abstract][Full Text] [Related]
28. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
Obana A; Gohto Y; Kaneda K; Nakajima S; Miki T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of laser-targeted photoocclusion of the choriocapillary layer in rats.
Asrani S; Zou S; D'Anna S; Lutty G; Vinores SA; Goldberg MF; Zeimer R
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2702-10. PubMed ID: 9418722
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
Miller JW; Walsh AW; Kramer M; Hasan T; Michaud N; Flotte TJ; Haimovici R; Gragoudas ES
Arch Ophthalmol; 1995 Jun; 113(6):810-8. PubMed ID: 7540388
[TBL] [Abstract][Full Text] [Related]
31. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
[TBL] [Abstract][Full Text] [Related]
32. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.
Reinke MH; Canakis C; Husain D; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Ophthalmology; 1999 Oct; 106(10):1915-23. PubMed ID: 10519585
[TBL] [Abstract][Full Text] [Related]
33. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
34. Exploitation of immune response-eliciting properties of hypocrellin photosensitizer SL052-based photodynamic therapy for eradication of malignant tumors.
Korbelik M; Merchant S; Huang N
Photochem Photobiol; 2009; 85(6):1418-24. PubMed ID: 19709384
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B.
Jiang Y; Leung AW; Wang X; Zhang H; Xu C
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):600-6. PubMed ID: 24284117
[TBL] [Abstract][Full Text] [Related]
36. In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba.
Chen Z; Xuguang S; Zhiqun W; Ran L
Br J Ophthalmol; 2008 Sep; 92(9):1283-6. PubMed ID: 18723746
[TBL] [Abstract][Full Text] [Related]
37. Cyclohexylamino-demethoxy-hypocrellin B and photodynamic therapy decreases human cancer in vitro.
Xu S; Chen S; Zhang M; Shen T; Liu Z; Zhao Y; Wu Y
Anticancer Drug Des; 2001 Dec; 16(6):271-7. PubMed ID: 12375880
[TBL] [Abstract][Full Text] [Related]
38. Threshold parameters for choroidal vessel closure with the photosensitizer, lambda 27.
Genaidy M; Kazi AA; Peyman GA; Farahat H; Kivilcim M; Laghari NA; Afzal S
J Coll Physicians Surg Pak; 2007 Apr; 17(4):215-8. PubMed ID: 17462179
[TBL] [Abstract][Full Text] [Related]
39. Photosensitization by anticancer agents 21: new perylene- and aminonaphthoquinones.
Diwu ZJ; Haugland RP; Liu J; Lown JW; Miller GG; Moore RB; Brown K; Tulip J; McPhee MS
Free Radic Biol Med; 1996; 20(4):589-93. PubMed ID: 8904300
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
